Insider filing · ABBV
Jeffrey Ryan Stewart sold $12.4M of AbbVie (ABBV)
Executed Mar 31 2025, disclosed Apr 2 2025, 2 days later.
Value, as filed
$12.4M
58,832 sh across 2 lots
Executed
Mar 31 2025
the trade date, as filed
Disclosed
Apr 2 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JS
Jeffrey Ryan Stewart
EVP, CHIEF COMMERCIAL OFFICER
profile →
Jeffrey Ryan Stewart (EVP, CHIEF COMMERCIAL OFFICER) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in AbbVie Inc. (ABBV). The largest single filing was $12.4M of ABBV (58,832 sh across 2 lots, as filed), executed Mar 31 2025.
The name
ABBV
AbbVie Inc.
ABBV · Healthcare · 41 filings in 24 months
ticker →
Healthcare · AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→